Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Position in ARGX — Argenx SE
CIK 2032331
SINGAPORE, U0
Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,074,765
+$3,716,311 QoQ
Shares Held
4,392
+803.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#158
of 504 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Derivatives in ARGX
reported options exposure · as of Mar 31, 2025CallValue
$769,424
CallShares
1,300
PutValue
$946,984
PutShares
1,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $37,479,746 across 39 Biotechnology names. ARGX ranks #1 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
4,392 | $4,074,765 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
13,831 | $3,385,413 | |
| 3 | INSM |
INSMED Inc
|
30,170 | $3,216,725 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
5,865 | $3,149,211 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
55,112 | $3,130,912 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
36,873 | $3,007,730 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,588 | $1,682,155 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
27,041 | $1,547,286 |
All Filings in ARGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,074,765 | 4,392 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $358,454 | 486 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $220,765 | 373 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $769,424 | 1,300 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $946,984 | 1,600 | Put | Defined | 2025-05-13 | |
| 2024-12-31 | $492,000 | 800 | Call | Defined | 2025-02-18 | |
| 2024-12-31 | $1,107,000 | 1,800 | Put | Defined | 2025-02-18 | |
| 2024-12-31 | $389,910 | 634 | Shares | Defined | 2025-02-18 | |
| No filing history on record for this holder in this stock. | ||||||